Recommended Pages at invivoblog.blogspot.com

The IN VIVO Blog: Merck Says Goodbye to Independent Biosimilars Unit

invivoblog.blogspot.com — “The IN VIVO Blog: Merck Says Goodbye to Independent Biosimilars UnitView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on April 26, 2012 at 9:47 pm By:

InVivoBlogChris Chris Morrison Health Communicator

IVB: Merck's biosimilars chief Mike Kamarck has left the company and the business is now part of MRL's biologics group: http://t.co/ATA65Kfk

1 month ago...

The IN VIVO Blog: First-in-human Implantable Drug Delivery Data Airing at AAAS

invivoblog.blogspot.com — “The IN VIVO Blog: First-in-human Implantable Drug Delivery Data Airing at AAASView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on February 16, 2012 at 7:07 pm By:

sstrumello Scott Strumello Patient Expert

The IN VIVO Blog: First-in-human Implantable Drug Delivery Data Airing at AAAS http://t.co/tuyyWXMS via @EBI_Tweets

3 months ago...

The IN VIVO Blog: Pfizer's Dolsten Sees a Bright Future for Xalkori and Pfizer Oncology

invivoblog.blogspot.com — “The IN VIVO Blog: Pfizer's Dolsten Sees a Bright Future for Xalkori and Pfizer OncologyView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on February 15, 2012 at 9:25 pm By:

InVivoBlogChris Chris Morrison Health Communicator

My colleague Mike Goodman, fresh off reporting a feature on Xalkori, talks to Mikael Dolsten at #BIOCEO2012 http://t.co/UKeiS8rn

3 months ago...

The IN VIVO Blog: Twas DOTW Before Christmas ...

invivoblog.blogspot.com — “The IN VIVO Blog: Twas DOTW Before Christmas ...View full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on December 23, 2011 at 11:31 am By:

InVivoBlogChris Chris Morrison Health Communicator

The term sheets were hung by the chimney with care, In hopes that St Gilead soon would be there ... http://t.co/LkOJUyqf

5 months ago...

The IN VIVO Blog: Deals of the Week Notes the Holiday Generosity

invivoblog.blogspot.com — “The IN VIVO Blog: Deals of the Week Notes the Holiday GenerosityView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on December 16, 2011 at 8:08 pm By:

InVivoBlogChris Chris Morrison Health Communicator

Do upfront alliance payments get larger as the calender rolls toward new year? just seem that way? Actually, they do: http://t.co/yWYUfSAA

5 months ago...

The IN VIVO Blog: 2011 M&A of the Year Nominee: Abbott/Abbott Pharma

invivoblog.blogspot.com — “The IN VIVO Blog: 2011 M&A of the Year Nominee: Abbott/Abbott PharmaView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on December 12, 2011 at 1:46 pm By:

InVivoBlogChris Chris Morrison Health Communicator

I spose this is a good time to note we've nominated Abbott/Rx for M&A of the Year (yes it's not technically M&A, but) http://t.co/77gfSzaT

6 months ago...

The IN VIVO Blog: Deals of the Week, Arlo, Ellen, and Eleven Billion Reasons to Invest in Biotechs

invivoblog.blogspot.com — “The IN VIVO Blog: Deals of the Week, Arlo, Ellen, and Eleven Billion Reasons to Invest in BiotechsView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on November 23, 2011 at 4:15 pm By:

InVivoBlogChris Chris Morrison Health Communicator

The IN VIVO Blog: Deals of the Week, Arlo, Ellen, and Eleven Billion Reasons to Invest in Biotechs: http://t.co/qmMS0y0f via @AddThis

6 months ago...

The IN VIVO Blog: Guest Post: In Oncology, Is Early Partnering The Name Of The Game?

invivoblog.blogspot.com — “The IN VIVO Blog: Guest Post: In Oncology, Is Early Partnering The Name Of The Game?View full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on November 16, 2011 at 10:04 pm By:

InVivoBlogChris Chris Morrison Health Communicator

@CampbellAllianc guests on IVblog, discussing a trend toward earlier stage onco deals [all part of a broad shft] -- see http://t.co/Qmc69nTP

6 months ago...

The IN VIVO Blog: Deals of the Week's Stamp Of Approval

invivoblog.blogspot.com — “The IN VIVO Blog: Deals of the Week's Stamp Of ApprovalView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on November 4, 2011 at 5:54 pm By:

The IN VIVO Blog: Deals of the Week Ponders: Is IND the New Biotech Dealmaking Sweet Spot?

invivoblog.blogspot.com — “The IN VIVO Blog: Deals of the Week Ponders: Is IND the New Biotech Dealmaking Sweet Spot?View full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on October 21, 2011 at 6:58 pm By:

InVivoBlogChris Chris Morrison Health Communicator

IVB posits: it's better to deal at IND or earlier than to push a drug candidate through to POC. Discuss: http://t.co/Tu7D6rxp

7 months ago...

The IN VIVO Blog: Help Name Abbott's Pharma Newco

invivoblog.blogspot.com — “The IN VIVO Blog: Help Name Abbott's Pharma NewcoView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on October 19, 2011 at 1:49 pm By:

The IN VIVO Blog: IVB Culture Corner: Device Wonkery on the Small and Big Screen

invivoblog.blogspot.com — “The IN VIVO Blog: IVB Culture Corner: Device Wonkery on the Small and Big ScreenView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on October 14, 2011 at 8:02 pm By:

InVivoBlogChris Chris Morrison Health Communicator

One of our device-focused colleagues on art (er, at least TV and film) imitating life (litigation) in the med-dev space http://t.co/X94EfuCQ

8 months ago...

The IN VIVO Blog: Professional Egos, Cultural Norms Clash At Xarelto AdComm

invivoblog.blogspot.com — “The IN VIVO Blog: Professional Egos, Cultural Norms Clash At Xarelto AdCommView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on September 21, 2011 at 11:45 am By:

InVivoBlogChris Chris Morrison Health Communicator

@PinkSheetSutter skillfully sums up the squabbles from the Xarelto Adcom, and implications for designing control arms http://t.co/hyrWcsBO

8 months ago...

The IN VIVO Blog: 2009 Exits/Financings DOTY Nominee: Vertex's Milestone Sale

invivoblog.blogspot.com — “The IN VIVO Blog: 2009 Exits/Financings DOTY Nominee: Vertex's Milestone SaleView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 2:46 pm By:

InVivoBlogChris Chris Morrison Health Communicator

one of my 2009 posts on Vertex's EU telaprevir milestone sale. i'm surprised we havent seen more deals like this. http://t.co/Gw62crLu

8 months ago...

The IN VIVO Blog: Deals of the Week: Riding in Cars with Pharma

invivoblog.blogspot.com — “The IN VIVO Blog: Deals of the Week: Riding in Cars with PharmaView full resource at invivoblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on September 16, 2011 at 7:53 pm By:

InVivoBlogChris Chris Morrison Health Communicator

In Vivo Blog's Deals of the week: Riding in Cars with Pharma http://t.co/SUnzw9ua (yes i worked hard on that MS Paint picture)

8 months ago...

 1 2 3 4 Next ›  Last »